SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0001015402-04-001290
Filing Date
2004-03-30
Accepted
2004-03-30 17:24:46
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA FORM 10KSB DOR 2003 form10ksb2003.htm 10KSB 1818464
3 EXHIBIT 31.1 exhibit31w1.htm EX-31.1 10020
4 EXHIBIT 31.2 exhibit31w2.htm EX-31.2 9875
5 EXHIBIT 32.1 exhibit32w1.htm EX-32.1 5635
6 EXHIBIT 32.2 exhibit32w2.htm EX-32.2 5627
7 FINCIAL CODE OF ETHICS codeofethics.htm EX-14.1 17693
8 EXHIBIT 10.9 U OF T AGREEMENT exhibit10w9.htm EX-10.9 171426
  Complete submission text file 0001015402-04-001290.txt   2041178
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-16929 | Film No.: 04702701
SIC: 2834 Pharmaceutical Preparations